T 2710/19 (Formulations of Pomalidomide / CELGENE) of 09.03.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T271019.20220309
- Date of decision
- 9 March 2022
- Case number
- T 2710/19
- Online on
- 14 March 2022
- Petition for review of
- -
- Application number
- 10720107.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- FORMULATIONS OF 4-AMINO-2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE-1,3-DIONE
- Applicant name
- Celgene Corporation
- Opponent name
- Teva Pharmaceutical Industries Ltd.
Generics [UK] Ltd
HGF Limited
STADA Arzneimittel AG
Hoffmann Eitle - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.